🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Elise Ishida & Albert Einstein College of Medicine - Official researchers generated human IgG monoclonal antibodies to AM/LAM from B cells of two asymptomatic individuals exposed to or latently infected with M. #tuberculosis. go.nature.com/3FClrAa

Out online now: Opinion piece on "Monoclonal antibodies to lipoarabinomannan/arabinomannan – characteristics and implications for tuberculosis research and diagnostics" Albert Einstein College of Medicine - Official Todd L. Lowary CSU Microbiology, Immunology & Pathology sciencedirect.com/science/articl…

In a paper published online today in Journal of Clinical Investigation, an Einstein research team led by Xingxing Zang, M.Med., Ph.D., describes its findings that could bolster the effectiveness of immune-checkpoint therapy. Learn more at: bit.ly/3hLB80o #cancer

The journey to bring research from the bench to bedside is long but exciting and achievable as shown by Acquired Resistance to Therapy Network (ARTNet) PI XingXing Zang Albert Einstein College of Medicine - Official during his presentation at the NCIARTNet scientific meeting today

Excited to have received the William R. Jacobs Jr. Award from the Microbiology and Immunology Department at Albert Einstein College of Medicine - Official. Thank you to my mentor XingXing Zang for your continued support! EinsteinPhD

Thrilled to share a new paper on Developmental Cell from a fruitful collaboration between Wenjun_Guo and my lab, showing the Sox9-B7x pathway in Breast Cancer immune evasion and a potential new Cancer Immunotherapy. EinsteinCellBio Albert Einstein College of Medicine - Official Montefiore Health System

Dr. XingXing Zang develops immune-checkpoint inhibitors (ICIs)—monoclonal antibodies that use the immune system to fight cancer cells. Two of his compounds are in clinical trials. He sees ICIs as the future of #LungCancertreatment. bit.ly/3QgV5Ke

Great congratulations to NextPoint!!!  It took 10 years moving from our original discovery of HHLA2 as a new B7 immune checkpoint in 2013 to NextPoint’s soon clinical trials in cancer patients. Albert Einstein College of Medicine - Official Montefiore Health System

Grateful Oscar Ortiz from SebastianStrong Foundation came to my office and present a check for our CAR research. My lab, David Loeb and Allison Martin are developing next-generation CAR-T therapy treating human pediatric Rhabdomyosarcoma. Albert Einstein College of Medicine - Official Montefiore Health System

My thoughts on Chimeric Antigen Receptor (CAR) immune-cell therapy. The next frontier for CAR therapy is solid cancers and autoimmune diseases, also holds promises for aging, Alzheimer’s disease, etc. The Next Chapter of Science | Technology Networks technologynetworks.com/informatics/ar…

Researchers at National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center have shown a breakthrough therapy for treating blood cancers can be adapted to treat solid #tumors—an advance that could transform cancer treatment. bit.ly/3yfefLm #CancerResearch #MECCC

I’m thrilled our paper on new CAR treating human solid cancers is out in Science Advances today. Huge credit to stellar student Einstein MSTP Christopher Nishimura, great collaborators Deyou Zheng D. Zheng and UT Southwestern Medical Center Cheng Cheng Zhang science.org/doi/10.1126/sc…

As our lab tradition, the whole lab out for lunch to celebrate first birthday of a new lab member Xiaona Sun Marc Pulanco Devin T. Corrigan Dr. Ankit Tanwar Jiabi Zhang Yunchao_Shentu @AndyLi81701371 Wang Yulin Yolanda Liu

Nice annual scientific retreat of Montefiore Einstein Comprehensive Cancer Center at the beautiful Glen Island Harbour Club.

Posters of four important and exciting research projects that are led by our lab members Marc Pulanco Marc Pulanco, Ankit Tanwar Dr. Ankit Tanwar, Devin Corrigan Devin T. Corrigan, Zidong (Andy) Li @AndyLi81701371.

Immunotherapy has revolutionized cancer care. Now National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. More at bit.ly/3B5vlwl. 1/2

Last week I was honored to receive the Barry R. Bloom speaker award for the top Work-in-Progress presentation in the Microbiology and Immunology department. Thank you to my mentor XingXing Zang for all of your support and guidance! Albert Einstein College of Medicine - Official EinsteinPhD

Join us for the IFI-Joint Lab Meeting featuring presentations; Devin T. Corrigan from XingXing Zang Lab and Divya Kenchappa from Saenger’s Lab!! Exciting Insights on Cancer Immunotherapy & Immune Cell Regulations!! EinsteinPhD EinsteinMSTP Albert Einstein College of Medicine - Official Montefiore Health System